ICD-10-CM Billable Code

B53.0

Plasmodium ovale malaria

Clinical Classification Guidelines

Excludes Type 1

  • Plasmodium ovale with Plasmodium falciparum (B50.-)
  • Plasmodium ovale with Plasmodium malariae (B52.-)
  • Plasmodium ovale with Plasmodium vivax (B51.-)

Medical Intelligence & Overview

Plasmodium ovale malaria is a type of malaria caused by the parasite Plasmodium ovale. This parasitic infection is transmitted through the bites of infected female Anopheles mosquitoes. Although less common than other forms of malaria, P. ovale malaria can cause significant health issues if not properly diagnosed and treated. Typically found in parts of West Africa and the Pacific, it tends to cause milder symptoms but can lead to serious complications in some cases.

Causes & Symptoms

Clinical Causes: Bite from an infected female Anopheles mosquito carrying Plasmodium ovale Blood transfusions or sharing needles with contaminated equipment, although less common Residual parasitic presence in areas where malaria is endemic

Key Symptoms: Fever that often rises in cycles, usually every 48 hours Chills and sweating episodes Headache and muscle aches Fatigue and weakness Mild nausea or gastrointestinal discomfort Splenomegaly (enlarged spleen) in some cases Possible anemia due to destruction of red blood cells

Diagnostic & Treatment

Diagnosis Path: Diagnosis of P. ovale malaria typically involves blood tests such as microscopic examination of blood smears to identify parasites. Sometimes, rapid diagnostic tests (RDTs) are used for a quick diagnosis, though microscopic confirmation is preferred for identifying the specific Plasmodium species. Blood tests may also be conducted to check for anemia or other related complications. Due to the cyclical nature of symptoms, timing of blood sample collection can be important.

Treatment Protocols: Treatment usually involves antimalarial medications tailored to combat Plasmodium ovale. The most common approach includes drugs like chloroquine to eliminate blood-stage parasites, followed by primaquine to target dormant liver forms called hypnozoites, which can cause relapses. Patients are advised to complete the full course of treatment and follow healthcare provider guidance to prevent recurrence. Supportive care, such as hydration and rest, can help manage symptoms, but specific treatment must be supervised professionally.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B53.0 a billable ICD-10 code?
Yes, B53.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B53.0?
Clinical documentation must specify the nature of Plasmodium ovale malaria and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

ovale plasmodium malaria